ADM adds to patents for soy isoflavones
for the use of concentrated isoflavones in combination with other
plant-derived phytochemicals.
Archer Daniels Midland has been awarded its fifth and sixth patents for the use of concentrated isoflavones in combination with other plant-derived phytochemicals.
The latest patents in the series cover plant-derived compositions enriched with at least two phytochemicals, from isoflavones, lignans, saponins, catechins and phenolic acids, that can be used to treat alcoholism and neurological symptoms.
"These additional patents illustrate our work with soy-derived isoflavones in combination with saponins and other concentrated phytochemicals which may prove useful in the treatment of alcohol dependency and in the treatment of neurological symptoms," said Tony DeLio, vice president of marketing and external affairs.
"In addition, isoflavones are commonly used in dietary supplements or added to certain foods to provide functional benefits."
ADM, which markets isoflavones under the brand name Novasoy, was awarded US patent 6,399,072 for the "Method of Preparing and Using Isoflavones for the Treatment of Alcoholism" and US patent 6,391,310 describing the "Method of Preparing and Using Isoflavones for the Treatment of Neurological Symptoms."
"These latest patents effectively reflect our commitment to the discovery and development of plant-derived ingredients that promote health and well being," added DeLio. "ADM remains dedicated to providing our customers with innovative products that distinguish our customers' products from their competitors."
Archer Daniels Midland, one of the world's largest processors of soybeans, corn, wheat and cocoa, and also a leader in soy meal, has lately been building on its specialty food ingredients, bioproducts and nutraceuticals. Net sales for the fiscal year ended 30 June 2002 were $23.5 billion.
